专利号:WO-2015036637-A1 优先权日:2013-09-13 标题:Method for the synthesis of kojibiose and the application thereof in the production of food and pharmaceutical compositions 发明人:DIEZ MUNICIO MARINA; MORENO ANDUJAR FRANCISCO JAVIER; HERRERO CALLEJA MIGUEL; MONTILLA CORREDERA ANTONIA 权利人:CONSEJO SUPERIOR INVESTIGACION 摘要:The invention relates to a method for the synthesis of kojibiose, characterised by its simplicity and high yield, using a starting reaction mixture containing, as the main compound thereof, the trisaccharide 2-α-D-glucopyranosyl-lactose, O-β-D-galactopyranosyl-(1→4)-O-[α-D-glucopyranosyl- (1→2)]-β-D-glucopyranose, and leucrose, lactose, fructose, glucose and saccharose, said method comprising steps of fermentation, hydrolysis and purification, allowing the production of a disaccharide with high added value, such as kojibiose, in a cost-effective manner. The invention also relates to the kojibiose produced by means of the method according to the invention, and to the use of same in the production of prebiotic food compositions in order to prevent pathologies relating to the gastrointestinal system, and pharmaceutical compositions for treating viral-type diseases or for delaying the digestion of carbohydrates.
专利号:US-4381400-A 优先权日:1981-02-27 标 题 :Process for the synthesis of isosorbide mononitrates 发明人:EMEURY JEAN-MARIE; WIMMER ERIC 权利人:POUDRES & EXPLOSIFS STE NALE 摘要:The invention relates to the synthesis of isosorbide mononitrates. n The process according to the invention consists in reacting a hydrazine derivative with isosorbide dinitrate, in a polar solvent medium. The reaction is preferably carried out at the reflux temperature of the solvent medium, with an excess of the hydrazine derivative. A preferred solvent medium is a mixture of tetrahydrofuran and methanol. The process leads to the preferential formation of isosorbitol-2-mononitrate, which is a coronary vasodilator.
专利号:US-9315483-B2 优先权日:2007-09-13 标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof 发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT 权利人:CONCERT PHARMACEUTICALS INC 摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.
专利号:WO-2022193577-A1 优先权日:2021-03-15 标题 :Synthesis method for isosorbide mononitrate and application thereof 发明人:XIAO HANWEN; FU YONGHONG; LIN FANGYU; Zheng Yuannv; LIN XIAOXUE; Tang Xiongzhao 权利人:CHINA MEHECO KANGLI PHARMA CO LTD 摘要:The present invention belongs to the field of pharmaceutical synthesis, and disclosed are a synthesis method for isosorbide mononitrate and the application thereof. The synthesis method for isosorbide mononitrate provided by the present invention involves using a one-pot method and comprises taking sorbitol, and adding the sorbitol to concentrated sulfuric acid; and after dehydration and ring closing, adding a nitrate to perform a nitration reaction, and then adding zinc powder to perform a reduction reaction to then obtain isosorbide mononitrate. The synthesis method has a simple process flow and high raw material utilization, and saves on production costs. The present invention is suitable for the synthesis of isosorbide mononitrate, and the obtained isosorbide mononitrate is used for the preparation of isosorbide mononitrate for injection.
专利号:US-2024222113-A1 优先权日:2022-12-29 标 题:Passivation of crystalline substrate for metal chalcogen material synthesis 发明人:NAYLOR CARL H; MAXEY KIRBY; OBRIEN KEVIN; DOROW CHELSEY; LEE SUDARAT; PENUMATCHA ASHISH VERMA; AVCI UYGAR; METZ MATTHEW; CLENDENNING SCOTT B; KAVRIK MAHMUT SAMI; LIN CHIA-CHING; KITAMURA Ande 权利人:INTEL CORP 摘要:Integrated circuit (IC) structures comprising transistors with metal chalcogenide channel material synthesized on a workpiece comprising a Group IV crystal. Prior to synthesis of the metal chalcogenide material, a passivation material is formed over the Group IV crystal to limit exposure of the substrate to the growth precursor gas(es) and thereby reduce a quantity of chalcogen species subsequently degassed from the workpiece. The passivation material may be applied to the front side, back side, and/or edge of a workpiece. The passivation material may be sacrificial or retained as a permanent feature of an IC structure. The passivation material may be advantageously amorphous and/or a compound comprising at least one of a metal or nitrogen that is good diffusion barrier and thermally stable at the metal chalcogenide synthesis temperatures.
专利号:US-2012178129-A1 优先权日:2009-05-11 标 题 :Gene synthesis method 发明人:LI MO HUANG; YANG JACKIE Y; WAI CHYE CHEONG; BODE MARCUS 权利人:LI MO HUANG; YANG JACKIE Y; WAI CHYE CHEONG; BODE MARCUS 摘要:The present invention relates to polymerase chain reaction (PCR)-based methods for the one-step synthesis of nucleic acid molecules, wherein the amplification primers used in said methods are designed such that they have two distinct melting temperatures in order to minimize the competition between polymerase cycling assembly (PCA) and polymerase chain reaction (PCR) amplification in the one-step nucleic acid synthesis and to maximize the emerging full-length amplification, as well as kits for use in such methods.
1: Li P, Zhang G, Zhou Z, Sun Y, Wang Y, Yang Y, Zhang X. The Effect of Solvents on the Crystal Morphology of Isosorbide Mononitrate and Its Molecular Mechanisms. Molecules. 2024 Jan 11;29(2):367. doi: 10.3390/molecules29020367. 2023:9878906. doi: 10.1155/2023/9878906. 3: Retraction: Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis. Int J Gynaecol Obstet. 2024 Feb;164(2):805. doi: 10.1002/ijgo.15297. Epub 2023 Dec 12. 308(5):1655. doi: 10.1007/s00404-023-07178-3. 40(10):4693. doi: 10.1007/s12325-023-02628-5. Erratum for: Adv Ther. 2023 Aug;40(8):3588-3597. 40(8):3588-3597. doi: 10.1007/s12325-023-02548-4. Epub 2023 Jun 17. Erratum in: Adv Ther. 2023 Aug 10;: Lacunar Intervention Trial-2 (LACI-2) Investigator Group. Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial. JAMA Neurol. 2023 Jul 1;80(7):682-692. doi: 10.1001/jamaneurol.2023.1526.
合成参考文献
摘要:Mintz Y. Comment to: dyspeptic complaints after 20 weeks of gestation are not related to Helicobacter pylori seropositivity Tanriverdi HA, Ustundag Y, Tekin IO, Barut A Med Sci Monit, 2005; 11(9): CR445-CR448. Med Sci Monit. 2005 Dec;11(12):LE21. 摘要:Abhishek A, Anushree A, Ashutosh, Ray S. Comment to: septic shock: current pathogenic concept from a clinical perspective Tsiotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J Med Sci Monit, 2005; 11(3): RA76-RA85 Future treatment perspectives in septic shock. Med Sci Monit. 2005 Dec;11(12):LE22–3; author reply LE23. 摘要:Carilli S. Comment to: topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions Al-Waili NS Med Sci Monit, 2004; 10(8): MT94-MT98. Med Sci Monit. 2005 Dec;11(12):LE24. 参考文献:10.2174/156720112802650635 摘要:Yoncheva K, Doytchinova I, Tankova L. Preparation and evaluation of isosorbide mononitrate hydrogels for topical fissure treatment. Curr Drug Deliv. 2012 Sep;9(5):452–8. doi: 10.2174/156720112802650635. 参考文献:10.1007/s00464-011-1799-6 摘要:Bittner R, Arregui ME, Bisgaard T, Dudai M, Ferzli GS, Fitzgibbons RJ, Fortelny RH, Klinge U, Kockerling F, Kuhry E, Kukleta J, Lomanto D, Misra MC, Montgomery A, Morales-Conde S, Reinpold W, Rosenberg J, Sauerland S, Schug-Paß C, Singh K, Timoney M, Weyhe D, Chowbey P. Guidelines for laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal Hernia [International Endohernia Society (IEHS)]. Surgical Endoscopy. 2011 Jul 13;25(9):2773. doi: 10.1007/s00464-011-1799-6.